What is the current Price Target for the Kala Pharmaceuticals, Inc. stock?

The average Kala Pharmaceuticals, Inc. target price is $32.13. This is 4,175.45% higher than the current stock price. The highest price target is 4,790.22%, the lowest is 3,259.95%. 6 Analysts have issued a price target Kala Pharmaceuticals, Inc. 2026 .

How high will the Kala Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Kala Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Kala Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kala Pharmaceuticals, Inc. stock today?

The performance of Kala Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kala Pharmaceuticals, Inc. stock fall?

The decline in Kala Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kala Pharmaceuticals, Inc. Forecast, price target & analysts

$0.75

1.34% yesterday

Nasdaq, Nov 04, 10:00 pm CET

ISIN

US4831191030

Symbol

KALA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Kala Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

Kala Pharmaceuticals, Inc. Classifications & Recommendation:

Hold

57%

Sell

43%

Kala Pharmaceuticals, Inc. Price Target

Target Price	$32.13
Price	$0.75
Potential	4,175.45% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Kala Pharmaceuticals, Inc. 2026 . The average Kala Pharmaceuticals, Inc. target price is $32.13. This is 4,175.45% register free of charge higher than the current stock price. The highest price target is $36.75 4,790.22% register free of charge , the lowest is $25.25 3,259.95% register free of charge .
	A rating was issued by 7 analysts: 0 Analysts recommend Kala Pharmaceuticals, Inc. to buy, 4 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kala Pharmaceuticals, Inc. stock has an average upside potential 2026 of 4,175.45% register free of charge . Most analysts recommend the Kala Pharmaceuticals, Inc. stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-10.26	-5.19
	40.86%	49.42%
P/E		negative

6 Analysts have issued a Kala Pharmaceuticals, Inc. forecast for earnings per share. The average Kala Pharmaceuticals, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-10.26	40.86%
2025	$-5.19 49.42% Unlock
2026	$-2.87 44.70% Unlock
2027	$-1.10 61.67% Unlock

Current	-0.13	73.32%
2025	-0.15 12.44% Unlock
2026	-0.27 80.00% Unlock
2027	-0.69 155.56% Unlock

Kala Pharmaceuticals, Inc....

Current Kala Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 29 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 17 2025
Oppenheimer	Locked ➜ Locked	Locked	Sep 11 2025
Mizuho	Locked ➜ Locked	Locked	Sep 08 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 23 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 04 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 13 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 29 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 17 2025
Locked Oppenheimer: Locked ➜ Locked	Sep 11 2025
Locked Mizuho: Locked ➜ Locked	Sep 08 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 23 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 04 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 13 2025

Discover more stocks with a high price target

TUI 59.10%

Adidas 53.89%

Deutsche Telekom 45.60%

Novo Nordisk 42.39%

Meta Platforms (Facebook) 41.54%

BYD 40.09%

BioNTech SE - ADR 33.30%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now